Individualized Medication Guidance for Gynecologic Cancer
Gynecologic Cancer Surgery
According to the latest Chinese women's new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the widespread clinical use of poly(ADP-ribose) polymerase (PARP) inhibitors, the progression-free survival (PFS) of ovarian cancer patients has been significantly prolonged. At present, the biomarkers related to PARP inhibitor treatment mainly include BRCA1/2 gene mutation, HRR gene mutation, etc., and some studies have found that about 50% of epithelial ovarian cancer patients have homologous recombination deficiency (homologous recombination deficiency, HRD).
Test Content of Individualized Medication Guidance for Gynecologic Cancer Care
This test detects 348 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for gynecologic cancer patients.
Applicable Population of Individualized Medication Guidance for Gynecologic Cancer Treatment
Late-stage newly diagnosed gynecologic cancer patients who need targeted therapy and immunotherapy.
Patients with relapsed, drug-resistant gynecologic cancer solution.
Gynecologic cancer patients who need targeted therapy and immunotherapy through liquid biopsy.
If you want to know more details of chemotherapy in gynaecology, radiotherapy in gynaecology, please visit our website.
As one of genetic sequencing companies, we can provide professional chip seq servicefor clients, if you are interested, please leave us a message.
在线联系供应商
Other supplier products
 |
Individualized Medication Guidance for Cancer (118 Genes) | This cancer genetic testdetects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlati... |
 |
Individualized Medication Guidance for Prostate Cancer | This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk as... |
 |
CapitalBio® Microarray Hybridization Station | CapitalBio® Microarray Hybridization Station The CapitalBio® BioMixerTMII is a microarray hybridization station that uses continuous 3-D m... |
![Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic]](/images/products/products_918645_3ed639acb6109822155d13588d134efd.jpeg) |
Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic] | This germline testingdetects somatic and germline SNV, InDel and CNV mutations in the BRCA1 and BRCA2 genes, covering the entire coding region of t... |
 |
CapitalBio® Microarray Scanner LuxScan™10K | The CapitalBio LuxScan™ 10K dna microarray scanneris a compact high performance system for microarray imaging and the analysis of DNA, protei... |
Same products
 |
Common Rail Fuel Injector Nozzle DLLA150P1746 | 卖方: China Lutong Part Plant | Common Rail Fuel Injector Nozzle DLLA150P1746 Tina #for Bosch 0 281 006 074 Pressure Control Val... |
 |
Automotive Parts & Accessories | 卖方: O&K GROUP LIMITED | Okwishing supplies all kinds of Automotive Parts & Accessories Okwishing () is a cross-borde... |
 |
Hontko HLS-S-10-1A-P Linear wire encoder | 卖方: 840499 | HLS-S series is an incremental wire-drawn encoder suitable for measuring shorter strokes Email: ... |
 |
OEM 23390-0L041 Auto Fuel Systems for Toyota | 卖方: Foshan Bohua Auto Parts Co., Ltd | OEM 23390-0L041 Auto Fuel Systemsfor Toyota The fuel filter is used to prevent particles, water ... |
 |
OEM Car Engine Timing Belt for Hyundai | 卖方: Foshan Bohua Auto Parts Co., Ltd | The OEM car engine timing beltis a genuine Hyundai part designed specifically for Hyundai vehicl... |
